GSK Releases Raw Data from Study 329


The inimitable 1 Boring Old Man stumbles on previously unreleased raw data from GlaxoSmithKline’s controversial study of paroxetine in adolescent depression (study 329). The data had been ordered to be released as part of a Paxil lawsuit that had been settled in 2004. 1 Boring Old Man finds that a comment from the first analysis states “the results of the studies were disappointing in that we did not reach statistical significance on the primary end points and thus the data do not support a label claim for the treatment of adolescent depression. The possibility of obtaining a safety statement from this data was considered but rejected.”

1 Boring Old Man → 


Support MIA

MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.

Select Payment Method
Personal Info

Credit Card Info
This is a secure SSL encrypted payment.

Billing Details

Donation Total: $20 One Time